Mustang Bio, Inc. granted extension to fix stock price
- Received notice April 15, 2026, for stock price below $1.00
- Initial 180-day grace period ended October 12, 2026
- Additional 180-day extension until April 12, 2027 granted
MBIO
MUSTANG BIO, INC. SEC filings
Every EDGAR filing for MUSTANG BIO, INC. (MBIO), newest first, with AI summaries and stories.
- Ticker
- MBIO
- CIK
- 1680048
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: 10-Q expected ~Nov 9 (deadline Nov 16) ยท earnings expected ~Nov 16
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KMUSTANG BIO, INC.MBIOLIVE NOTABLE10-QMUSTANG BIO, INC.MBIOLIVE NOTABLE10-QMUSTANG BIO, INC.MBIOLIVE ROUTINE4MUSTANG BIO, INC.MBIOLIVE Manuel MD Litchman, insider filing for MBIO
Manuel Litchman Md, reporting
ROUTINE8-KMUSTANG BIO, INC.MBIOLIVE NOTABLE10-KMUSTANG BIO, INC.MBIOLIVE NOTABLESCHEDULE 13D/AMUSTANG BIO, INC.MBIOLIVE Ownership stake disclosure by Fortress Biotech, Inc. (amended)
Fortress Biotech, Inc., filed by
ROUTINE4MUSTANG BIO, INC.MBIOLIVE Fortress Biotech, Inc., insider filing for MBIO
Fortress Biotech, Inc., reporting
ROUTINE4MUSTANG BIO, INC.MBIOLIVE 3 insider filings
Neil Herskowitz, insider filing for MBIO
Show all 3
- 4Insider filing for MBIO
- 4Insider filing for MBIO
- 4Insider filing for MBIO
Neil Herskowitz, reporting
ROUTINE8-KMUSTANG BIO, INC.MBIOLIVE ROUTINEDEF 14AMUSTANG BIO, INC.MBIOLIVE NOTABLE10-QMUSTANG BIO, INC.MBIOLIVE